CRSP Today - Aug 12: Mixed Signals for CRISPR

カートのアイテムが多すぎます

ご購入は五十タイトルがカートに入っている場合のみです。

カートに追加できませんでした。

しばらく経ってから再度お試しください。

ウィッシュリストに追加できませんでした。

しばらく経ってから再度お試しください。

ほしい物リストの削除に失敗しました。

しばらく経ってから再度お試しください。

ポッドキャストのフォローに失敗しました

ポッドキャストのフォロー解除に失敗しました

CRSP Today - Aug 12: Mixed Signals for CRISPR

無料で聴く

ポッドキャストの詳細を見る

Hey there! It’s Joey, your friendly longtime investor, here to break down what went down with CRISPR Therapeutics today. So, CRSP had a bit of a red day, slipping down by half a percent. Yeah, that one stung a little.

Now, let’s get into the nitty-gritty. The stock barely moved, but there’s some chatter around the company that’s worth mentioning. They reported stronger revenue and a narrower loss, which is usually a good sign. People love to see that kind of progress! But it seems like the market's still trying to figure out what to make of it all. Sometimes, good news doesn’t translate into stock gains right away, and today was one of those days.

In the background, CRISPR’s CFO, Prasad Raju, made a little splash by gifting 750 shares. That’s kind of a cool move, right? It shows some confidence in the company. Meanwhile, it looks like Quantinno Capital Management is raising its position in CRISPR. That’s definitely something to keep an eye on, as it suggests some folks are still betting on the future here.

Now, here's a quick fact for you: the FDA recently approved some products for three biotech companies, which is huge news for the industry. This could be a game-changer for CRISPR and its peers, so it’s worth watching how that plays out.

So, to wrap it up, CRSP had a quiet day, but there’s some interesting stuff happening behind the scenes. Always good to keep your ears to the ground! Remember, this is just for fun and to keep you informed, not financial advice. Catch you later!

まだレビューはありません